DJIA 15,908.37 248.19 1.58%
NASDAQ 4,321.64 54.81 1.28%
S&P 500 1,856.02 26.94 1.47%
market minute promo

GlaxoSmithKline (NYSE: GSK)

39.45 0.30 (0.77%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

GSK $39.47 0.80%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $38.95
Previous Close $39.15
Daily Range $38.91 - $39.56
52-Week Range $37.24 - $49.08
Market Cap $96.1B
P/E Ratio 13.45
Dividend (Yield) $2.33 (6.0%)
Ex-Dividend Date
Dividend Pay Date
02/17/16
04/14/16
Volume 2,016,208
Average Daily Volume 4,371,038
Current FY EPS $2.38

Sector

Healthcare

Industry

Drug Makers

GlaxoSmithKline (GSK) Description

The Company is a global healthcare group which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter medicines and health-related consumer products. Website: http://www.gsk.com/

News & Commentary Rss Feed

Can NewLink Genetics Win the Zika Vaccine Race?

Does NewLink's success with Ebola suggest it can do the same with Zika?

Health Care Sector Update for 02/12/2016: GSK, NVS

Brandes Makes a Variety of Reductions in 4th Quarter

This Week In Pharma: Questions About Dynavax And Alnylam

These O'Shares ETFs Focus On Quality European Dividends

Why Ionis Pharmaceuticals Inc Plunged 36% in January

Sometimes bad things can happen to good companies.

4 Can't-Miss Numbers From GlaxoSmithKline's Fourth-Quarter Results

GlaxoSmithKline's headline numbers might have been lackluster, but dig below the surface and you'll uncover these crucial data points.

Is Inovio Pharmaceuticals' Zika Surge Premature?

The biotech's stock has heated up recently with fears about the Zika virus. Too much too fast?

Glaxo Tops Q4 Earnings, Revenues Rise Y/Y, 2016 View Intact

Opportunities Abound in Healthcare

See More GSK News...

GSK's Top Competitors

GSK $39.45 (0.77%)
Current stock: GSK
JNJ $101.00 (-0.69%)
Current stock: JNJ
PFE $29.10 (-0.10%)
Current stock: PFE
NVS $72.31 (0.15%)
Current stock: NVS